AP-180 Activators are a selectively curated set of chemical compounds that interface with the cellular machinery to enhance the functional activity of AP-180, a protein central to clathrin-mediated endocytosis. Phosphatidylinositol 4,5-bisphosphate (PIP2) directly interacts with AP-180, promoting its ability to foster clathrin lattice formation, a pivotal step in vesicle assembly. Dynasore, a dynamin inhibitor, might increase AP-180 activity as a compensatory response to interrupted endocytosis. Similarly, Amiloride and Monodansylcadaverine, by respectively modulating intracellular ion concentrations and stabilizing clathrin-coated vesicles, could indirectly elevate AP-180's assembly function. Methyl-β-cyclodextrin, by altering membrane cholesterol content, and Nystatin, through its interaction with membrane sterols, may both influence AP-180's role by perturbing the membrane environment conducive to efficient endocytic vesicle formation. Additionally, Okadaic Acid, a potent phosphatase inhibitor, could facilitate AP-180's role by inducing a hyperphosphorylated state that favors endocytic processes.
The functional spectrum of AP-180 is further enhanced by compounds that modulate accessory proteins and membrane dynamics. The presence of an increased pool of Clathrin Triskelion and the interaction with Adaptor Protein 2 (AP2) are presumed to synergistically boost AP-180's efficiency in vesicle formation. Pitstop 2, by selectively inhibiting clathrin's terminal domain, may indirectly necessitate an upregulation of AP-180's activity to maintain endocytic flux. The K+ Ionophore, although primarily affecting membrane potential, might subtly influence the endocytic pathway, thereby necessitating an enhanced role for AP-180. Collectively, these compounds, through their targeted effects on various facets of the endocytic pathway, act to potentiate the fundamental role of AP-180 in clathrin-mediated vesicle formation and trafficking within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a GTPase inhibitor that specifically inhibits dynamin. By inhibiting dynamin, endocytosis is transiently blocked, which can lead to compensatory mechanisms that upregulate AP-180 activity to restore function. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride is a Na+/H+ exchange inhibitor that can increase intracellular hydrogen concentration, affecting endocytic pathway activity and possibly enhancing AP-180’s role in vesicle formation. | ||||||
Dansylcadaverine | 10121-91-2 | sc-214851 sc-214851A sc-214851B | 100 mg 250 mg 1 g | $52.00 $89.00 $240.00 | 4 | |
This is an inhibitor of transglutaminase and is known to accumulate in clathrin-coated vesicles, potentially stabilizing them and indirectly enhancing the function of AP-180. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 is a clathrin terminal domain inhibitor that blocks the function of clathrin without affecting AP-180, potentially upregulating AP-180 activity to compensate for inhibited clathrin function. | ||||||
Methyl-β-cyclodextrin | 128446-36-6 | sc-215379A sc-215379 sc-215379C sc-215379B | 100 mg 1 g 10 g 5 g | $20.00 $48.00 $160.00 $82.00 | 19 | |
This compound extracts cholesterol from membranes, disrupting lipid rafts and potentially enhancing clathrin-mediated endocytosis, which could upregulate AP-180 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a phosphatase inhibitor that can lead to hyperphosphorylation of proteins, potentially affecting endocytic pathways and AP-180 activity as a compensatory mechanism. | ||||||